Axis Direct
Furthermore, the raw material prices for API manufacturing have shown softness which will support the company's growth in the upcoming quarters. We recommend HOLD with the target price of Rs 540/share.
Aarti Drugs Ltd. is trading above its 200 day SMA of 437.0
More from Aarti Drugs Ltd.
Recommended